一项关于静脉注射30U茴香酰化纤溶酶原链激酶激活剂复合物治疗急性心肌梗死的安慰剂对照通畅性研究。 - Suppr | 超能文献

A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction.

作者信息

de Bono D P

机构信息

Cardiac Department, Royal Infirmary, Edinburgh.

出版信息

Drugs. 1987;33 Suppl 3:138-9. doi: 10.2165/00003495-198700333-00022.

DOI:10.2165/00003495-198700333-00022

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction.一项关于静脉注射30U茴香酰化纤溶酶原链激酶激活剂复合物治疗急性心肌梗死的安慰剂对照通畅性研究。

Drugs. 1987;33 Suppl 3:138-9. doi: 10.2165/00003495-198700333-00022.

2

Biological study of intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.静脉注射茴香酰化纤溶酶原链激酶激活剂复合物治疗急性心肌梗死的生物学研究

Drugs. 1987;33 Suppl 3:268-74. doi: 10.2165/00003495-198700333-00049.

3

Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.急性心肌梗死患者中两种静脉溶栓药物（茴香酰化纤溶酶原链激酶激活剂复合物与链激酶）的评估。

Drugs. 1987;33 Suppl 3:169-74. doi: 10.2165/00003495-198700333-00028.

4

Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.链激酶和茴香酰化纤维蛋白溶酶原链激酶激活剂复合物静脉推注用于急性心肌梗死。临床和血液学检查结果。

Drugs. 1987;33 Suppl 3:183-5. doi: 10.2165/00003495-198700333-00031.

5

Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与静脉注射链激酶治疗进展性心肌梗死的比较。一项随机多中心研究的初步数据。

Drugs. 1987;33 Suppl 3:140-5. doi: 10.2165/00003495-198700333-00023.

6

Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).急性心肌梗死中静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与肝素随机研究中左心室功能的评估。欧洲多中心研究（比利时中心）的初步结果

Drugs. 1987;33 Suppl 3:216-20. doi: 10.2165/00003495-198700333-00037.

7

Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.对茴香酰化纤溶酶原链激酶激活剂复合物静脉治疗急性心肌梗死的早期临床评估。

Drugs. 1987;33 Suppl 3:112-6. doi: 10.2165/00003495-198700333-00018.

8

AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee.目的。开展一项多中心死亡率研究，比较静脉注射安慰剂与30单位茴香酰化纤溶酶原链激酶激活剂复合物治疗病程小于6小时的急性心肌梗死的效果。英国茴香酰化纤溶酶原链激酶激活剂复合物咨询委员会。

Drugs. 1987;33 Suppl 3:227-8. doi: 10.2165/00003495-198700333-00040.

9

Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.

Drugs. 1987;33 Suppl 3:151-3. doi: 10.2165/00003495-198700333-00025.

10

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.急性心肌梗死静脉注射茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）的多中心再灌注试验：与冠状动脉内链激酶的对照比较

J Am Coll Cardiol. 1988 Jun;11(6):1153-63. doi: 10.1016/0735-1097(88)90276-8.

本文引用的文献

1

Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.静脉注射茴香酰化纤溶酶原-链激酶复合物BRL 26921进行冠状动脉溶栓治疗。

Br Heart J. 1985 Mar;53(3):253-9. doi: 10.1136/hrt.53.3.253.